ApprovalTrail

Approval · Notice of Compliance 2976 · 1998

DUOVENT UDV: Notice of Compliance 2976

Issued November 12, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2976
Date
November 12, 1998
Company
Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Product monograph update
Therapeutic class
Bronchodilator

Products in this notice

BrandDINStatus today
DUOVENT UDVNot yet assigned—

Medicinal ingredients